by Charles Champlin When his vision became seriously impaired, a writer learned to cope by doing what he loved best. (Published in the Los Angeles Times, June 24, 2001. Reprinted by permission.) Charles Champlin Is the former film critic, arts editor and critic-at-large columnist for the Los Angeles Times. He retired in 1991. This piece [Read More]
News
Second Trial Showing Efficacy for Stem Cell Treatment of Dry AMD
A second trial begun in 2018 is showing positive results with replacing defective cells leading to vision loss from dry (geographic) macular degeneration. Implanted cells derived from stem cells have been implanted into five patients by researchers from University of Southern California (USC) and the University of California, Santa Barbara. Results at one year have [Read More]
Gout Associated With Increased Risk of AMD
A recent study by researchers at the University of Alabama at Birmingham School of Medicine, has looked into the association between age-related macular degeneration (AMD) and gout. Gout is a form of arthritis resulting from inflammation in the joints caused by the build-up of uric acid crystals and is associated with oxidative stress. The main [Read More]
Novel Gene Therapy In Trials for Wet AMD
(Updated 10/12/19) Adverum Biotechnologies, Inc. has announced progress with yet another therapy designed to extend the time between anti-VEGF injections for treatment of wet age-related macular degeneration (wAMD). The company’s Investigational New Drug (IND) application has been approved for a multi-center study of ADVM-022, a novel gene therapy candidate for the treatment of wAMD. “We [Read More]
What Are The Highest Priorities in AMD Research?
Four eye health stakeholder groups have come together to help define the focus of research in age-related macular degeneration (AMD). Their purpose was to prioritize clinical questions important for researchers to answer when developing clinical practice guidelines and identifying treatment outcomes important to patients. Participants in the initiative were: American Academy of Ophthalmology (AAO) Retina/Vitreous [Read More]